By continuing to use our site, you consent to the processing of cookies, user data (location information, type and version of the OS, the type and version of the browser, the type of device and the resolution of its screen, the source of where the user came from, from which site or for what advertisement, language OS and Browser, which pages are opened and to which buttons the user presses, ip-address) for the purpose of site functioning, retargeting and statistical surveys and reviews. If you do not want your data to be processed, please leave the site.
The Voice of People With Breast Cancer
Education
Publications
& Resources
Workshop: Deconstructing Clinical Trials
Led by Dr. Jan-Willem Henning, MD, FRCPC, a seasoned oncologist with extensive experience in breast cancer trials, this session introduces patients to key terms—such as control arms, adverse events, survival rates, and response measures—in a way that bridges scientific language with practical understanding. Gain confidence in interpreting study results, making it easier to engage with your care team and make informed decisions.
Expert Speaker:
Dr. Jan-Willem Henning is a Clinical Associate Professor and Medical Oncologist at the Arthur Child Comprehensive Cancer Centre in Calgary Alberta and Cumming School of Medicine, University of Calgary. He received his medical degree (MBChB) in 1999 from the University of Orange Free State, South Africa and after immigrating to Canada; he received his certification of specialty training in Internal Medicine and Medical Oncology at the Royal College of Canada (FRCPC). His areas of clinical expertise include Breast Cancer, Sarcoma and Adolescent and Young Adult (AYA) Oncology. Dr. Henning is the immediate past program director for the medical oncology residency program in Calgary, and currently serves as the chair-elect for the Royal College Subspecialty Training Program for Medical Oncology. His research interest includes leading phase I-III clinical trials as well as health services research in AYA-oncology, Breast Cancer and Sarcoma. Dr. Henning is the current chair for the REAL (Research Excellence, Active Leadership) Canadian Breast Cancer Alliance. He has published in several international peer-reviewed journals, including the Lancet of Oncology.
Please complete our post-video survey! Your input helps us to bring you the content that's important to you.
Click for our webinar definitions guide.
Resources:
https://cbcn.ca/en/blog/our-stories/common-research-terms
https://cbcn.ca/en/blog/our-stories/reading-research
https://cbcn.ca/en/clinical-trials-connected
https://www.cbcn.ca/en/QandEwebinar-clinical-trials-2023
https://cbcn.ca/en/listing-directory/decisions-and-pathways/resources-on-clinical-trials
https://cbcn.ca/en/blog/our-stories/debunking-common-myths-about-clinical-trials
https://cbcn.ca/en/blog/our-stories/Clinical-Trials-What-Are-They
SHARE
Our Stories
Events
Receive updates by email Subscribe Now
About CBCN
CBCN strives to voice the views and concerns of breast cancer patients through education, advocacy activities, and the promotion of information sharing.
Canadian Breast Cancer Network
185 Somerset St. West Suite 318, Ottawa, ON Canada K2P 0J2
Tel: 613-230-3044
Toll-free: 1-800-685-8820
Email Us
